Melatonin Al (Melatonin)

Melatonin binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, the central clock that controls circadian rhythms. Activation of these receptors signals nighttime, helping to synchronize internal biological rhythms and facilitate the transition to sleep.

The appropriate dose of Melatonin Al is determined by a prescriber based on the individual’s age, condition, and response. Healthcare professionals consider factors such as the severity of insomnia or the number of time zones crossed when recommending a specific regimen.

Safety data for melatonin use during pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Melatonin Al.

To request Melatonin Al, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike prescription hypnotics that act on GABA receptors, melatonin works by mimicking the natural sleep hormone and resetting circadian rhythms. This mechanism generally results in fewer next‑day residual effects, but its efficacy may be more modest for severe insomnia compared with stronger sedative agents.

Melatonin Al should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its potency throughout its shelf life.

Melatonin Al is taken orally, usually as a tablet or capsule, with water. It is typically taken shortly before bedtime, following the dosage instructions provided by the prescribing clinician.

Serious but rare risks include severe allergic reactions such as rash, itching, swelling, or difficulty breathing, and rare cases of pronounced dizziness or mood changes. Patients should seek immediate medical attention if they experience any of these symptoms.

Melatonin Al is not recommended for individuals with known hypersensitivity to melatonin, for children unless specifically prescribed, or for patients with uncontrolled severe hepatic impairment without medical supervision. Anyone with a complex medical history should consult a healthcare professional before starting therapy.